Wed, April 5, 2017
Tue, April 4, 2017
Mon, April 3, 2017

Madhu Kumar Upgraded (ABUS) to Strong Buy and Increased Target to $6 on, Apr 4th, 2017

Madhu Kumar of Chardan Capital, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Strong Buy and Increased Target from $3 to $6 on, Apr 4th, 2017.

Madhu, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30